Hmdb loader
Survey
Record Information
Version5.0
StatusExpected but not Quantified
Creation Date2009-04-06 16:19:41 UTC
Update Date2023-02-21 17:17:38 UTC
HMDB IDHMDB0012128
Secondary Accession Numbers
  • HMDB12128
Metabolite Identification
Common Name(R)-Amphetamine
Description(R)-amphetamine is an enantiomer of amphetamine that is urinary metabolite from selegeline (drug used for the treatment of early-stage Parkinson's disease, depression and senile dementia). (R)-amphetamine as stereoisomer is not considered psychoactive and has little abuse potential. The stimulatory effect on locomotor activity and dopamine synthesis may be contributed to by the action of R-methamphetamine. If anyone is prescribed and takes selegiline, they can and will test positive for amphetamine/methamphetamine on most drug tests.
Structure
Data?1676999858
Synonyms
ValueSource
(-)-AmphetamineChEBI
(-)-PhenylisopropylamineChEBI
(R)-alpha-MethylbenzeneethanamineChEBI
(R)-alpha-MethylphenethylamineChEBI
LevamfetamineChEBI
LevamphetamineChEBI
(R)-a-MethylbenzeneethanamineGenerator
(R)-Α-methylbenzeneethanamineGenerator
(R)-a-MethylphenethylamineGenerator
(R)-Α-methylphenethylamineGenerator
AmfetamineMeSH
AmphetamineMeSH
Amphetamine sulfateMeSH
Amphetamine sulfate (2:1)MeSH
CentraminaMeSH
DesoxynorephedrinMeSH
FenamineMeSH
LevoamphetamineMeSH
MydrialMeSH
PhenamineMeSH
PhenoprominMeSH
Sulfate, amphetamineMeSH
ThyramineMeSH
L AmphetamineMeSH
Levo amphetamineMeSH
Levo-amphetamineMeSH
(R)-a-Methyl-benzeneethanamineHMDB
(R)-alpha-Methyl-benzeneethanamineHMDB
(R)-PhenaminumHMDB
(R)-PhenylisopropylamineHMDB
L-(R)-AmphetamineHMDB
L-a-MethylphenethylamineHMDB
L-alpha-MethylphenethylamineHMDB
L-AmphetamineHMDB
Miquel brand OF amfetamine sulfateMeSH, HMDB
Chemical FormulaC9H13N
Average Molecular Weight135.2062
Monoisotopic Molecular Weight135.104799421
IUPAC Name(2R)-1-phenylpropan-2-amine
Traditional Name(-)-amphetamine
CAS Registry Number156-34-3
SMILES
C[C@@H](N)CC1=CC=CC=C1
InChI Identifier
InChI=1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3/t8-/m1/s1
InChI KeyKWTSXDURSIMDCE-MRVPVSSYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as amphetamines and derivatives. These are organic compounds containing or derived from 1-phenylpropan-2-amine.
KingdomOrganic compounds
Super ClassBenzenoids
ClassBenzene and substituted derivatives
Sub ClassPhenethylamines
Direct ParentAmphetamines and derivatives
Alternative Parents
Substituents
  • Amphetamine or derivatives
  • Phenylpropane
  • Aralkylamine
  • Organic nitrogen compound
  • Organopnictogen compound
  • Hydrocarbon derivative
  • Primary amine
  • Organonitrogen compound
  • Primary aliphatic amine
  • Amine
  • Aromatic homomonocyclic compound
Molecular FrameworkAromatic homomonocyclic compounds
External Descriptors
Ontology
Physiological effectNot Available
DispositionNot Available
ProcessNot Available
Role
Physical Properties
StateSolid
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
Water Solubility1.74 g/LALOGPS
logP1.85ALOGPS
logP1.8ChemAxon
logS-1.9ALOGPS
pKa (Strongest Basic)10.01ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count1ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area26.02 ŲChemAxon
Rotatable Bond Count2ChemAxon
Refractivity43.71 m³·mol⁻¹ChemAxon
Polarizability16.18 ųChemAxon
Number of Rings1ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DarkChem[M+H]+130.75231661259
DarkChem[M-H]-127.69231661259
DeepCCS[M+H]+133.02230932474
DeepCCS[M-H]-130.15930932474
DeepCCS[M-2H]-166.35230932474
DeepCCS[M+Na]+141.75530932474
AllCCS[M+H]+129.132859911
AllCCS[M+H-H2O]+124.532859911
AllCCS[M+NH4]+133.532859911
AllCCS[M+Na]+134.832859911
AllCCS[M-H]-131.132859911
AllCCS[M+Na-2H]-132.932859911
AllCCS[M+HCOO]-134.932859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
(R)-AmphetamineC[C@@H](N)CC1=CC=CC=C11645.8Standard polar33892256
(R)-AmphetamineC[C@@H](N)CC1=CC=CC=C11128.0Standard non polar33892256
(R)-AmphetamineC[C@@H](N)CC1=CC=CC=C11147.6Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
(R)-Amphetamine,1TMS,isomer #1C[C@H](CC1=CC=CC=C1)N[Si](C)(C)C1334.7Semi standard non polar33892256
(R)-Amphetamine,1TMS,isomer #1C[C@H](CC1=CC=CC=C1)N[Si](C)(C)C1339.0Standard non polar33892256
(R)-Amphetamine,1TMS,isomer #1C[C@H](CC1=CC=CC=C1)N[Si](C)(C)C1618.3Standard polar33892256
(R)-Amphetamine,2TMS,isomer #1C[C@H](CC1=CC=CC=C1)N([Si](C)(C)C)[Si](C)(C)C1539.5Semi standard non polar33892256
(R)-Amphetamine,2TMS,isomer #1C[C@H](CC1=CC=CC=C1)N([Si](C)(C)C)[Si](C)(C)C1524.0Standard non polar33892256
(R)-Amphetamine,2TMS,isomer #1C[C@H](CC1=CC=CC=C1)N([Si](C)(C)C)[Si](C)(C)C1644.4Standard polar33892256
(R)-Amphetamine,1TBDMS,isomer #1C[C@H](CC1=CC=CC=C1)N[Si](C)(C)C(C)(C)C1564.4Semi standard non polar33892256
(R)-Amphetamine,1TBDMS,isomer #1C[C@H](CC1=CC=CC=C1)N[Si](C)(C)C(C)(C)C1562.5Standard non polar33892256
(R)-Amphetamine,1TBDMS,isomer #1C[C@H](CC1=CC=CC=C1)N[Si](C)(C)C(C)(C)C1758.8Standard polar33892256
(R)-Amphetamine,2TBDMS,isomer #1C[C@H](CC1=CC=CC=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C1970.2Semi standard non polar33892256
(R)-Amphetamine,2TBDMS,isomer #1C[C@H](CC1=CC=CC=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C1936.9Standard non polar33892256
(R)-Amphetamine,2TBDMS,isomer #1C[C@H](CC1=CC=CC=C1)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C1881.7Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - (R)-Amphetamine GC-MS (Non-derivatized) - 70eV, Positivesplash10-0006-9100000000-41224b447ebed58b4d862017-09-01Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - (R)-Amphetamine GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - (R)-Amphetamine 10V, Positive-QTOFsplash10-00kr-0900000000-b3a524d7c495f48a74c32017-09-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - (R)-Amphetamine 20V, Positive-QTOFsplash10-014r-1900000000-081ce3a25bbacda4ab982017-09-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - (R)-Amphetamine 40V, Positive-QTOFsplash10-0006-9300000000-5195de4351c8a02eb2322017-09-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - (R)-Amphetamine 10V, Negative-QTOFsplash10-001i-0900000000-22cd79bae5466b52ae0a2017-09-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - (R)-Amphetamine 20V, Negative-QTOFsplash10-001i-1900000000-a4e4f7fb040e60f9e5ba2017-09-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - (R)-Amphetamine 40V, Negative-QTOFsplash10-014l-4900000000-e652b091af97ea288b4c2017-09-01Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - (R)-Amphetamine 10V, Positive-QTOFsplash10-00kf-6900000000-4f5d22828acdcb13d83e2021-09-23Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - (R)-Amphetamine 20V, Positive-QTOFsplash10-0006-9000000000-c5766ace6b20313023362021-09-23Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - (R)-Amphetamine 40V, Positive-QTOFsplash10-0006-9000000000-c8535cbb285cac9995902021-09-23Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - (R)-Amphetamine 10V, Negative-QTOFsplash10-0006-9200000000-0f66be3239e5e65d60282021-09-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - (R)-Amphetamine 20V, Negative-QTOFsplash10-0006-9100000000-6720c563d36a88e31cd62021-09-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - (R)-Amphetamine 40V, Negative-QTOFsplash10-002f-9000000000-f91f5b5177c2d32668fd2021-09-25Wishart LabView Spectrum

NMR Spectra

Spectrum TypeDescriptionDeposition DateSourceView
Predicted 1D NMR1H NMR Spectrum (1D, 100 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 100 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 1000 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 1000 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 200 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 200 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 300 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 300 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 400 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 400 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 500 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 500 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 600 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 600 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 700 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 700 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 800 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 800 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 900 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 900 MHz, D2O, predicted)2021-09-25Wishart LabView Spectrum

IR Spectra

Spectrum TypeDescriptionDeposition DateSourceView
Predicted IR SpectrumIR Ion Spectrum (Quadrupole Ion Trap, ESI+, Adduct: [M+H]+)2022-02-11FELIX labView Spectrum
Predicted IR SpectrumIR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-)2023-02-03FELIX labView Spectrum
Predicted IR SpectrumIR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+)2023-02-03FELIX labView Spectrum
Predicted IR SpectrumIR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+)2023-02-03FELIX labView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen LocationsNot Available
Tissue LocationsNot Available
Pathways
Normal Concentrations
Not Available
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDFDB028792
KNApSAcK IDNot Available
Chemspider ID30477
KEGG Compound IDC07514
BioCyc IDCPD-7659
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound32893
PDB IDFRD
ChEBI ID42724
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Sulzer D, Sonders MS, Poulsen NW, Galli A: Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol. 2005 Apr;75(6):406-33. [PubMed:15955613 ]
  2. Chaudhry IA, Turkanis SA, Karler R: Characteristics of "reverse tolerance" to amphetamine-induced locomotor stimulation in mice. Neuropharmacology. 1988 Aug;27(8):777-81. [PubMed:3216957 ]
  3. Leith NJ, Kuczenski R: Chronic amphetamine: tolerance and reverse tolerance reflect different behavioral actions of the drug. Pharmacol Biochem Behav. 1981 Sep;15(3):399-404. [PubMed:7291243 ]
  4. Sax KW, Strakowski SM: Behavioral sensitization in humans. J Addict Dis. 2001;20(3):55-65. [PubMed:11681593 ]
  5. Glennon RA, Yousif M, Patrick G: Stimulus properties of 1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDA) analogs. Pharmacol Biochem Behav. 1988 Mar;29(3):443-9. [PubMed:2896360 ]